1286862

Aurobindo Pharma Limited — FEI 3004446312

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 5, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Medchal (India)